MedPath

Propyphenazone

Generic Name
Propyphenazone
Drug Type
Small Molecule
Chemical Formula
C14H18N2O
CAS Number
479-92-5
Unique Ingredient Identifier
OED8FV75PY

Overview

No overview information available.

Indication

No indication information available.

Associated Conditions

  • Headache
  • Menstrual Pain
  • Pain
  • Rheumatism
  • Rheumatism, Muscular
  • Toothache
  • Mild to moderate pain

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor

No clinical trials found

No clinical trials found for this drug

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
SARIDON TAB
N/A
N/A
N/A
2/4/1985

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.

Health Canada Drug Approvals

Approved Product
Company
DIN
Dosage Form
Strength
Market Date
No Health Canada approvals found for this drug.

CIMA AEMPS Drug Approvals

Approved Product
Company
Registration Number
Pharmaceutical Form
Prescription Type
Status
SARIDON 250 mg/150 mg/50 mg COMPRIMIDOS
Bayer Hispania S.L.
4384
COMPRIMIDO
Sin Receta
Commercialized
DOLODENS 100 mg/15 mg/10 mg COMPRIMIDOS RECUBIERTOS
Farmalider S.A.
41846
COMPRIMIDO
Medicamento Sujeto A Prescripción Médica
Commercialized
SARIDON 250 MG/150 MG/50 MG COMPRIMIDOS
Bayer B.V.
RVG 03780
COMPRIMIDO
Sin Receta
Commercialized
SARIDON 250 MG/150 MG/50 MG COMPRIMIDOS
Bayer Uab
LT1940863001
COMPRIMIDO
Sin Receta
Not Commercialized
OPTALIDON 500 MG/75MG SUPOSITORIOS
Perrigo Espana S.A.
14517
SUPOSITORIO
Sin Receta
Commercialized
OPTALIDON GRAGEAS
Perrigo Espana S.A.
3941
COMPRIMIDO
Sin Receta
Not Commercialized

Philippines FDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product
Company
Registration Number
Dosage Form
Strength
Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name
MA Holder
MA Number
Pharmaceutical Form
Active Ingredient
Authorization Date
No UK EMC drug information found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.